Lataa...

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy

T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and eff...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Gregori, Silvia, Passerini, Laura, Roncarolo, Maria-Grazia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4658444/
https://ncbi.nlm.nih.gov/pubmed/26635807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00593
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!